Medical Pharmacology Chapter 35  Antibacterial Drugs

Section Table of Contents

Site Table of Contents

Previous Page

Next Page

  • Penicillin G and Penicillin V Pharmacology and Therapeutics

    • Therapeutic uses

      • Streptococcal Infections

        Streptococcal Infections:  Audio Overview
        • Penicillin is the first-line treatment for streptococcal pharyngitis (strep throat) caused by Streptococcus pyogenes (Group A strep).1 

          • Dosing regimens for penicillin as well as amoxicillin have been described.2 

            • Penicillin eradicates S. pyogenes and prevents complications like rheumatic fever.3 

              • Penicillin V is also used for mild to moderate streptococcal skin infections such as erysipelas or uncomplicated cellulitis.4,5,6

                • Facial erysipelas infection
                  • Facial erysipelas infection, a disease characterized by superficial layer skin infection (upper dermis). Erysipelas is a type of cellulitis and may be serious.5 

                  • Attribution

              •  Group B Streptococcus (S. agalactiae) infections for example in. neonatal sepsis and prophylaxis in obstetrics may be treated with IV penicillin. In women with penicillin allergy clindamycin may be an alternative.7  

              • Penicillin G (often in combination with gentamicin or another agent) is also a drug of choice for enterococcal endocarditis caused by Enterococcus faecalis (if susceptible), using high-dose IV penicillin G plus an aminoglycoside (gentamicin)  for synergy.8

      • Syphilis and Spirochetal Infections

        Syphilis and Spirochetal Infections:  Audio Overview

        • Penicillin G is the gold-standard therapy for syphilis, in all stages.9  

          • Treponema pallidum
            • Histopathology of Treponema pallidum spirochetes using modified Steiner silver stain. (Obtained from the CDC Public Health Image Library)

            • Attribution

              • CDC, Public domain, via Wikimedia Commons

              • Image credit: CDC/Dr. Edwin P. Ewing, Jr, 1986.

          • Treponema pallidum is exquisitely sensitive to penicillin G.9 

          • Early syphilis is treated in primary care or infectious disease clinics with a single IM dose of benzathine penicillin G (2.4 million units) to achieve sustained low-level penicillin in the blood.10 

          • Late latent syphilis requires three weekly IM doses, and neurosyphilis or ocular syphilis requires high-dose IV penicillin G for 10–14 days.11,12

        • Penicillin G (IV) is also recommended for neonatal congenital syphilis13 and, along with azithromycin, for Treponema pertenue infections (yaws).14  

        • Other spirochetal infections treated with penicillin include Leptospirosis (IV penicillin G).15 

      • Pneumococcal Infections

        Pneumococcal Infections:  Audio Overview
        • Streptococcus pneumoniae (pneumococcus) historically was penicillin-sensitive and penicillin G was first-line for pneumococcal pneumonia23, meningitis, and otitis media.

          • Streptococcus pneumoniae
          • Due to resistance resulting from genetic mutations that alter penicillin-binding protein structure, management now depends on local susceptibility.16,17 

        • Penicillin G IV is still used for pneumococcal meningitis (Streptococcus pneumoniae) if the isolate is susceptible (MIC ≤0.06 μg/mL for meningitis); otherwise, third-generation cephalosporins, such as cefotaxime or ceftriaxone, may be appropriate.18 

        • For pneumococcal pneumonia, penicillin G IM or IV can be used if the strain is confirmed sensitive.19 

          • In outpatient primary care, amoxicillin (an oral aminopenicillin) has often replaced penicillin V for empiric treatment of community-acquired pneumonia, noting that Streptococcus pneumoniae is the bacteria most frequently isolated.20

            • Amoxicillin remains an antibiotic of preference in treating acute otitis media.22

               

              Otitis Media Audio Overview

              •  

                Otitis Media

              • Second-line alternatives in case of treatment failure include oral cefuroxime or amoxicillin-clavulanate.21 

August, 2025

Section Table of Contents

Site Table of Contents

 
References
  1.  CDC. Group A Strep Infection. Clinical Guidance for Group A Steptococcal Pharyngitis. Health Care care providers August 5, 2025. https://www.cdc.gov/group-a-strep/hcp/clinical-guidance/strep-throat.html

  2. Ashurst J Weiss E Tristam D Edgerley-Gibb L Streptococcal Pharyngitis. StatPearls. National Library of Medicine. (Last update: February 15, 2025). https://www.ncbi.nlm.nih.gov/books/NBK525997/

  3. Cattoir V  Chapter 30: Mechanisms of Streptococcus pyrogenes Antibiotic Resistance; Streptococcus pyrogenes: Basic Biology to Clinical Manifestations (Internet). Second edition. (Last update: October 9, 2022) https://www.ncbi.nlm.nih.gov/books/NBK587098/

  4. Herchline T Cellulitis Treatment & Management. (Updated: December 30, 2024). Medscape. https://emedicine.medscape.com/article/214222-treatment

  5. Erysipelas. https://en.wikipedia.org/wiki/Erysipelas

  6. Overview: Erysipelas and cellulitis. InformedHealth.org (Internet). National Library of Medicine. (Last update: July 8, 2025). https://www.ncbi.nlm.nih.gov/books/NBK303996/

  7. Morgan J Zafar N Cooper D Group B Streptococcus in Pregnancy. StatPearls. National Library of Medicine. (Last update: August 11, 2024). https://www.ncbi.nlm.nih.gov/books/NBK482443/

  8. Herrera-Hidalgo L Fernandez-Rubio B Luque-Marquez R Lopez-Cortes L Gil-Navarro M de Alarcon A Treatment of Enterococcus faecalis Infective Endocarditis: A Continuing Challenge. Antibiotics (Basel). 2023 April 4;12(4): 704.

  9. Jaiswal A Gomes L de Oliveira A de Castro Soares Azevedo V The Critical Role of Penicillin in Syphilis Treatment and Emerging Resistance Challenges. Diseases. 2025 January 31;13(2): 41. https://pmc.ncbi.nlm.nih.gov/articles/PMC11854480/

  10. CDC. Sexually Transmitted Infections Treatment Guidelines, 2021. Primary and Secondary Syphilis. https://www.cdc.gov/std/treatment-guidelines/p-and-s-syphilis.htm

  11. CDC. Tertiary Syphilis. Sexually Transmitted Infections Treatment Guidelines, 2021. https://www.cdc.gov/std/treatment-guidelines/tertiary-syphilis.htm

  12. CDC. Sexually Transmitted Infections Treatment Guidelines, 2021. Neurosyphilis, Ocular Syphilis, and Otosyphilis. https://www.cdc.gov/std/treatment-guidelines/neurosyphilis.htm

  13. CDC. Sexually Transmitted Infections Treatment Guidelines, 2021. Congenital Syphilis. https://www.cdc.gov/std/treatment-guidelines/congenital-syphilis.htm

  14. Yaws World Health Organization (WHO) January 12, 2023. https://www.who.int/news-room/fact-sheets/detail/yaws

  15. Gompf S Leptospirosis Medication. (Updated: July 31, 2024) Medscape. https://emedicine.medscape.com/article/220563-medication#2

  16. Jacobs M R Drug-resistant Streptococcus pneumoniae: rational antibiotic choices. Review: Am J Med. 1999 May 3;106(A 5): 19S-25S. https://pubmed.ncbi.nlm.nih.gov/10348060/

  17. CDC Pneumococcal Disease. Antibiotic-resistant Streptococcus pneumoniae. Public Health: December 17, 2024. https://www.cdc.gov/pneumococcal/php/drug-resistance/index.html

  18. Vasudeva S Meningitis Treatment & Management. (Updated: February 6, 2025). Medscape. https://emedicine.medscape.com/article/232915-treatment#d8

  19. Komagamine J The efficacy of high-dose penicillin G for pneumococcal pneumonia diagnosed based on initial comprehensive assessment at admission: an observational study. BMC Res Notes. 2018 June 20;11:399. https://pmc.ncbi.nlm.nih.gov/articles/PMC6011604/

  20. Llor C Perez A Carandell E Garcia-Sangenis A Rezola J Llorente M Gestoso S Bobe F Roman-Rodriguez M Cots J Hernandez S Cortes J Miravitlles M Morros R Efficacy of high doses of penicillin versus amoxicillin in the treatment of uncomplicated community acquired pneumonia in adults. A non-inferiority controlled clinical trial. Aten Primaria. 2017 October 20;51(1): 32-39. https://pmc.ncbi.nlm.nih.gov/articles/PMC6836912/

  21. Michichero M Acute hepatitis Media: Part II. Treatment in an Era of Increasing Antibiotic Resistance. Am Fam Physician. 2000;61(8): 2410-2416. https://www.aafp.org/pubs/afp/issues/2000/0415/p2410.html

  22. Harmes K Blackwood R Burrows H Cooke J Van Harrison R Passamani P Otitis Media: Diagnosis and Treatment. Am Fam Physician. 2013; 88(7): 435-440. https://www.aafp.org/pubs/afp/issues/2013/1001/p435.html

  23. CDC Pneumococcal Disease. About Pneumococcal Disease. (Updated: October 31, 2024). https://www.cdc.gov/pneumococcal/about/index.html

 

This Web-based pharmacology and disease-based integrated teaching site is based on reference materials, that are believed reliable and consistent with standards accepted at the time of development. Possibility of human error and on-going research and development in medical sciences do not allow assurance that the information contained herein is in every respect accurate or complete. Users should confirm the information contained herein with other sources. This site should only be considered as a teaching aid for undergraduate and graduate biomedical education and is intended only as a teaching site. Information contained here should not be used for patient management and should not be used as a substitute for consultation with practicing medical professionals. Users of this website should check the product information sheet included in the package of any drug they plan to administer to be certain that the information contained in this site is accurate and that changes have not been made in the recommended dose or in the contraindications for administration.  Advertisements that appear on this site are not reviewed for content accuracy and it is the responsibility of users of this website to make individual assessments concerning this information.  Medical or other information  thus obtained should not be used as a substitute for consultation with practicing medical or scientific or other professionals.